Ottobock appointed Katarzyna Mazur-Hofsaess, MD, PhD, to its management board. She succeeds Stefan Heidenreich, whose five-year term ended.
“With Katarzyna, we are gaining a proven expert in international medical technology and healthcare. Her experience in global companies and her medical background will be a valuable addition to our board,” said Hans Georg Näder, chairman of the management board.
Mazur-Hofsaess has years of international experience in medical technology and healthcare. From 2018 to 2025, she was a member of the management board of Fresenius Medical Care and CEO of medical-technology company Care Enablement.
A physician by training, Mazur-Hofsaess studied and earned her doctorate at the Medical University of Gdańsk. She also completed management studies at the Warsaw School of Economics and the University of Minnesota. She began her professional career at the University Clinical Centre in Gdańsk.
